Region: China

New IAM legal research tool aids busy patent professionals in the global licensing landscape

“Primary Sources” can fast-forward your queries about jurisdictions around the world

06 July 2024

IP is a global business

Saturday Opinion: China is becoming increasingly self-sufficient, but complex technologies make innovation hard to achieve alone

29 June 2024

Read everything about IP finance and insurance in IAM’s latest Special Report

IAM’s Special Report 2024 Q2 "Money, money, money” reports deeply on the growing breadth of IP financial products spreading across the globe

28 June 2024

IP valuation and finance in Asia: where are we at?

Featured in Special Report 2024 Q2: Money, money, money

28 June 2024

Foreword

Featured in Special Report 2024 Q2: Money, money, money

28 June 2024

Chinese courts can now set SEP rates for foreign patent pools

Landmark Supreme People’s Court decision is a win for TCL in long-running dispute against Access Advance

27 June 2024

Supreme People’s Court redefines use in trade secret infringement case with record-breaking damages award 

Featured in Trade Secrets Hub 2024

The Supreme People’s Court is providing stronger protection for trade secrets in a recent high-profile ruling. The judgment highlights the court’s inference of infringement during litigation and sets a new precedent for Chinese courts deciding on trade secret matters. 

26 June 2024

Building a robust trade secret strategy in China

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

Life sciences companies should look to China’s recent legislation and court decisions as a framework to build a robust China IP strategy that integrates both patents and trade secrets.

24 June 2024

IP experts remain positive in the face of changes to the global life sciences landscape

AI, counterfeits and legislative overhauls are changing the game but contributors to the IAM Guide to Life Sciences offer strategic steps to help companies stay one step ahead

24 June 2024

Leveraging injunctive relief in pharmaceutical patent disputes in China

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

Preliminary injunctions play a pivotal role in pharma patent infringement suits, serving as a crucial procedural tool for patentees to protect their IP rights. However, these offer significant advantages, pharma companies must exercise caution due to the risks associated with wrongful preservation.

24 June 2024

Unlock unlimited access to all IAM content